An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

CompletedOBSERVATIONAL

Enrollment

1,300

Participants

Timeline

Start Date

January 18, 2018

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions

Breast Cancer FemaleBreast Neoplasm Female

Trial Locations (3)

Bucheon Soonchunhyang University Hospital, Bucheon-si

Wonju Severance Christian Hospital, Wŏnju

Pusan National University Yangsan Hospital, Yangsan

All Listed Sponsors

lead

Kyowa Kirin Korea Co., Ltd.

INDUSTRY

NCT03433560 - An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®) | Biotech Hunter | Biotech Hunter